Freegold Ventures (TSX:FVL) Announces $30 Million Private Placement Financing

VANCOUVER, BC — December 18, 2025 — Leads & Copy —

Freegold Ventures Limited (TSX: FVL) (OTCQX: FGOVF) has announced an agreement with Paradigm Capital Inc., where Paradigm will serve as the lead agent and sole bookrunner for a syndicate of agents. Together, they will facilitate a brokered “best efforts” private placement financing to raise $30,000,100 for Freegold Ventures.

The financing will consist of 23,077,000 common shares of the company, priced at $1.30 per share.

Freegold Ventures has granted the agents an option to sell additional common shares, up to 15% of the base offering size. This option can be exercised by providing written notice to the company no less than 48 hours before the closing date.

The company plans to use the net proceeds from the offering to complete a Pre-Feasibility Study for the Golden Summit Project, support ongoing exploration efforts, and for general corporate and working capital needs. Management anticipates that these funds will enhance the company’s ability to advance the Golden Summit Project through the pre-feasibility stage.

The common shares will be offered for sale under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption, to purchasers resident in each of the provinces of Canada (other than Québec), and in other qualifying jurisdictions outside of Canada that are mutually agreed to by the Company and the Agents pursuant to relevant prospectus or registration exemptions in accordance with applicable laws. Because the offering is completed under the Listed Issuer Financing Exemption, the common shares issued will not be subject to a hold period in Canada under applicable Canadian securities laws.

An offering document related to this financing is available on SEDAR+ and the company’s website.

The offering is expected to close around January 6, 2026, pending regulatory approvals and customary closing conditions, including the listing of the common shares on the Toronto Stock Exchange.

On the closing date, the agents will receive a cash commission equal to 5% of the gross proceeds from the offering, including any proceeds from the exercise of the agents’ option.

These securities have not been registered under the United States Securities Act of 1933, nor any U.S. state securities laws, and may not be offered or sold in the United States without registration or compliance with an applicable exemption. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States.

Freegold Ventures is a TSX-listed company focused on exploration in Alaska.

Source: Freegold Ventures Limited

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.